Position in PCVX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$14,154,771
+$7,609,784 QoQ
Shares Held
243,502
+116.2% QoQ
Ownership
0.164%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#70
of 329 holders
Holding Since
Jun 2024
7 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WCM INVESTMENT MANAGEMENT, LLC holds $756,689,660 across 19 Biotechnology names. PCVX ranks #4 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,152,094 | $572,279,652 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
75,713 | $18,532,271 | |
| 3 | KYMR |
Kymera Therapeutics, Inc.
|
151,810 | $17,408,052 | |
| 4 | PCVX |
Vaxcyte, Inc.
This page
|
243,502 | $14,154,771 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
44,570 | $14,088,131 | |
| 6 | TECH |
BIO-TECHNE Corp
|
197,933 | $13,983,966 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
171,232 | $13,957,120 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
22,985 | $12,341,795 |
All Filings in PCVX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,154,771 | 243,502 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $6,544,987 | 112,631 | Shares | Sole | 2026-05-07 | |
| 2025-06-30 | $2,287,793 | 70,372 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $2,698,971 | 71,477 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $5,901,614 | 72,094 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $16,094,586 | 140,847 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $6,969,875 | 92,304 | Shares | Sole | 2024-07-31 | |
| No filing history on record for this holder in this stock. | ||||||